Document Type : Short Communication

Authors

1 Center for Healthcare Data Modeling, Department of Biostatistics and Epidemiology, School of Public Health, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

2 HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

3 Modeling in Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

4 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

5 Department of Medical Informatics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

6 Social Determinants of Health Research Center, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran

Abstract

Background: The prevalence of infections among general population can affect the prevalence among blood donors. Due to to the importance of blood safety, this study was conducted to estimate the prevalence of HIV, HBV, and HCV in donated bloods in Iran in 2018.
Methods: Using information of 1,308,284 blood donors, we designed this cross-sectional study to estimate the prevalence of transfusion-transmitted infections (TTIs) in Iranian blood donors. All the prevalence was reported per 100,000 population.
Results: HIV prevalence in blood donors was about 2 per 100,000 (95% CI: 1.999, 2.001) population. Prevalence of HBV and HCV was 53(95% CI: 52.999-53.00) and 26 (95% CI: 25.999-26.001), respectively.
Conclusion: It seems that the screening of volunteers would defer many people who may have been infected with TTIs; as a result, people with the least risk of being infected are selected to donate blood. Notice: All of these infected bloods were detected and discarded from the blood donation chain.

Keywords

  1. Yildiz SM, Candevir A, Kibar F, Karaboga G, Turhan FT, Kis C, et al. Hepatitis B, Hepatitis C, Human immunodeficiency virus and syphilis frequency among blood donors: A single center study. Transfus. Apheresis Sc. 2015;53(3):308-14. PMID: 26070837        doi:10.1016/j.transci.2015.05.022.
  2. Soodejani MT, Haghdoost AA, Sedaghat A, Baneshi MR, Zolala F. The Trends of Viral Hepatitis B and C and HIV Infections in Donated Bloods in Iran Between 2003 and 2017. J. Blood Med. 2019;10:435. doi:  1186/1471-2334-10-111  PMID: 20459703 PMCID: PMC2881920.
  3. Haghdoost A, Sedaghat A, Baneshi M, Zolala F. The increasing trend of blood donation in Iran. Blood Res.. 2019;54(4):269-73. doi: 10.5045/br.2019.54.4.269  PMID: 31915653 PMCID: PMC6942136.
  4. Tessema B, Yismaw G, Kassu A, Amsalu A, Mulu A, Emmrich F, et al. Seroprevalence of HIV, HBV, HCV and syphilis infections among blood donors at Gondar University Teaching Hospital, Northwest Ethiopia: declining trends over a period of five years. BMC Infect. Dis.. 2010;10(1):111. doi: 10.1186/1471-2334-10-111  PMID: 20459703 PMCID: PMC2881920.
  5. Sajjadi SM, Pourfathollah AA, Mohammadi S, Nouri B, Hassanzadeh R, Rad F. The prevalence and trends of hepatitis B, hepatitis C, and HIV among voluntary blood donors in kohgiluyeh and boyer-ahmad transfusion center, Southwestern J. Public Health. 2018;47(7):944.       PMID: 30181991 PMCID: PMC6119582.
  6. Keshvari M, Sharafi H, Alavian SM, Mehrabadi H, Zolfaghari S. Prevalence and trends of transfusion-transmitted infections among blood donors in Tehran, Iran from 2008 to 2013. Transfus. Apher.. 2015;53(1):38-47. doi: 10.1016/j.transci.2015.03.00 PMID: 25892591.
  7. Saber HR, Tabatabaee SM, Abasian A, Jamali M, SalekMoghadam E, Hajibeigi B, et al. Incidence and residual risk of HIV, HBV and HCV infections among blood donors in Tehran. Indian J Hematol Blood Transfus. 2017;33(3):412-6. doi: 10.1007/s12288-016-0732-5 PMID: 28824247 PMCID: PMC5544631.